Paul D. Crowe
Orphagen Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Stress Responses and Cortisol, Immunotherapy and Immune Responses, Receptor Mechanisms and Signaling, Hormonal Regulation and Hypertension, Immune Response and Inflammation
Most-Cited Works
- → The performance prism in practice(2001)641 cited
- → Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial(2000)513 cited
- → A Lymphotoxin-β-Specific Receptor(1994)393 cited
- → The Ligands and Receptors of the Lymphotoxin System(1995)256 cited
- → A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.(1995)232 cited
- → A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin(2001)210 cited
- → Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells